Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rationale and design of a clinical trial of a low-molecular-weight heparin in preventing clincally important venous thromboembolis in medical patients: the Prospective Evaluation of Dalteparin Efficacy for Prevention of Venous Thromboembolism in Immobilized Patients Trial (the PREVENT study)

Rationale and design of a clinical trial of a low-molecular-weight heparin in preventing clincally important venous thromboembolis in medical patients: the Prospective Evaluation of Dalteparin Efficacy for Prevention of Venous Thromboembolism in Immobilized Patients Trial (the PREVENT study). Vascular Medicine. 2002; 7:269-73.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.